Update to Recommendations to Protect Children Under Age 12, their Families and Communities

Building on the progress that has already been made with implementation of our first set of recommendations, the Vaccine Equity Cooperative Kids Vaccine Working Group created additional recommendations that respond to the slow progress of COVID-19 vaccinations for children, the decline in routine childhood immunizations, and the release of Omicron-specific boosters this fall.

 

In 2021, in anticipation of the COVID-19 vaccination rollout for children ages 5 to 11 years old, the Vaccine Equity Cooperative Kids Vaccine Working Group created a set of detailed recommendations to ensure all children, especially those who are most often underserved by existing systems, communities, receive equitable access to the COVID-19 vaccine. These recommendations rallied a diverse Working Group of concerned individuals and organizations in support of equitable vaccine coverage with a “no wrong door” approach.

In the fall of 2021, the Working Group met one-on-one with and then convened various government leaders at different stages of the vaccine rollout to help implement these recommendations and build and strengthen collaborations and connections for future partnerships. The Working Group appreciated the spirit of collaboration and support with which the recommendations were met, and the actions taken on the recommendations (e.g., reimbursement for vaccine counseling). Since then, the Working Group has continued to meet while tracking vaccine rollout and supporting uptake through our organizations and foundations.

Omicron cases and its variants continue to tax our vastly under-resourced health, public health, education and child care systems and personnel, with 14,195,580 total child COVID-19 cases reported, with children representing 18.5% (14,195,580/76,885,307) of all cases. Now that our children are returning to school and with only nascent research on the longer-term impacts of COVID-19 on children, we must take decisive action to protect them from COVID-19 and other diseases that can be addressed by routine immunizations.

Yet, COVID-19 vaccination rates remain low amongst children – especially very young children – with high state-by-state variability. A coordinated “all hands on deck” approach across federal and state agencies is critical at this time, in response to this dangerous gap in child vaccinations and the persistent disinformation designed to cast doubt in parents and guardians’ choices to vaccinate their children. The unprecedented silencing of experts who advocate for vaccines makes the battle to end vaccine-preventable diseases and keep children healthy that much more difficult. The recent resurgence of measles worldwide and polio in New York is further proof that the impact of anti-vaccination and disinformation campaigns are dangerously far-reaching and contributing to new health risks for a number diseases and populations.

Our national response to COVID-19 cannot regress. It must progress toward an equitable and comprehensive strategy to protect our children from any and all preventable infections, illnesses, hospitalizations and deaths. As funders and practitioners who are deeply committed to the health and well-being of children, we are grateful that there are safe and effective vaccines against COVID-19 for children from infancy through adolescence. We also recognize that uptake of this life-saving vaccine has been incomplete at best and inadequate at worst, to protect the nation, at every age group, from COVID-19 and its potential complications. This means that ideally vaccination efforts would focus on all age groups simultaneously.

However, in the face of foreshortened time, funds and public attention, we believe it is prudent to focus on vaccinating school-age children. This will help create safer learning environments for children who have already experienced significant learning disruption and loss over the past two years. This does not diminish the importance of vaccinating the 0 to 5 year old group, but rather presents an opportunity to gain traction among parents who have not yet vaccinated their school-age children. Focusing on families that include school-age children will ensure that, in the face of likely additional surges of COVID-19 in the fall and winter, these children can remain in school, safely. To build on the progress that has already been made with implementation of our first set of recommendations, the Working Group is providing additional recommendations that respond to the slow progress of COVID-19 vaccinations for children, the decline in routine childhood immunizations, and the release of Omicron-specific boosters this fall.

Short-term recommendations actionable over the next ~eight weeks:

In the near term, the Working Group suggests the following actions re: what can be done in the short term, with the Administration considering how to advance these actions promptly to ensure long-term value. If the federal government does not have these authorities, this group would like to discuss a mitigation plan.

1. Ensure the roles within the United States government are clearly defined and resourced for kids vaccines, COVID-19 response and school preparedness

While there has been proactive and well-intentioned activity, it is unclear how vaccine operations, coordination and communication operate within and across agencies including the CDC, HHS, and the White House – as well as the USDA and Department of Education. Creating a position for a singular lead across COVID-19 response and a singular point person for both routine childhood immunizations and COVID-19 vaccination will aid in resolving interagency, intra-agency, and external confusion about leadership, enhance coordination and communication across government agencies by establishing regular convenings, bolster public-private / nonprofit partnerships and support the empowered inclusion of trusted messengers on the ground (e.g., pediatricians, community health workers/Promotoras, educators and others). In addition, it will be critical to integrate the administration and resourcing of COVID-19 vaccination along with routine immunizations. The recent GAO report similarly calls for this kind of role and message clarity from HHS. Moreover, given the ongoing need, naming a singular lead should be implemented such that net capacity is added to the response team.

In addition, we recommend the childhood vaccination lead work in partnership with the American Academy of Pediatrics and others, including the National Association of School Nurses and National Association of Community Health Clinics, on all related kids vaccine communications and logistics for pediatricians to inform the policies, practices, and processes that will impact their patients and communities. This includes supporting and encouraging routine childhood vaccination within the primary care medical home – which will create opportunities to administer COVID-19 alongside holistic primary care services including access to other recommended vaccines, counsel on immunization, and provision of well child and mental health care.

2. Reassess assets and reopen the National Vaccine Program Office (NVPO) to centralize assets and coordinate with the forthcoming HHS Children’s Coordinating Council in the Office of the Secretary

With the urgent needs driven by COVID-19, the current assets within the government should be better centralized so that agencies that have subject matter experts and/or vaccine “leads” can coordinate their efforts within and across agencies. For example, the former National Vaccine Program Office within HHS, which the previous administration combined with the HIV/AIDS effort to create the Office of Infectious Disease and HIV/AIDS Policy (OIDP), could be reinstated and focused on developing guidance and technical support on vaccine communications. Even with limited resources within that group, an existing interagency vaccine task force is developing the nation’s immunization strategy for 2021-2025.

3. Create, disseminate, and amplify unified messages on all matters related to COVID-19 response

While the science on COVID-19 vaccines, testing, PPE, masking, treatment and coordination of care has been consistent and clear, information about that science has lacked the clarity and consistency required to make such science common knowledge. An overarching public health communication strategy must center on trusted messengers who present layered, affirming, and clear messages to normalize testing, masking, vaccination and treatment. This should be done alongside processes that democratize access to these pillars of the pandemic response.To be frank, the CDC has lost a concerning amount of public and professional confidence as this trusted messenger. Platforming and elevating new voices will require evaluating and amending current vaccine communications, ensuring messages are consistent for diverse audiences across agency websites, and leveraging various communication channels and messengers to spread the information. These messengers should include school-based champions of critical messages (administration, school-based clinics and nurses) community-based organizations, faith-based organizations and local community leaders and other trusted groups.

Another communication challenge that has emerged is that changes to clinical guidance have not been clear or well-disseminated. Specific attention should be paid to enhancing relationships and improving communications between federal agencies and state and local officials implementing the response, including more permissive guidance on how states and locals can use federal funding to resource community-based organizations to do outreach and education. This will be critical as COVID-19 is part of our day-to-day lives and in preparing for the next large-scale health crisis.

Clear, unified messaging has the power to undermine long-term efforts seeking to diminish the public credibility of government agencies and , under-resource, dismantle and remove the authority of these agencies. In the face of such anti-democratic efforts, public health systems must proactively move in tandem to shore up their legitimacy and proclaim their impact.

4. Establish a strategic roadmap to combat vaccine disinformation and build vaccine literacy

The COVID-19 vaccine roll out has served as an evolving opportunity to disseminate misinformation about vaccines, coordinate disinformation attacks about COVID-19, and launch anti-democratic campaigns more generally. Anti-science has gained traction, at least in part, because of insufficient vaccine and health literacy that predates the pandemic. This challenge is likely to worsen as state and federal governments move beyond “warp speed.” In addition, the current checkerboard of mandates for masks and vaccines, along with the inherent complexity across available vaccines and therapeutics authorized and approved by the FDA, together foster confusion and hinder care uptake, particularly among communities already under-served by the existing health information landscape Indigenous, Black, AAPI, Latina/o/e, and other communities of color.

Given this context, and the history that precedes it, pandemic/endemic response leaders must put forth a comprehensive plan to combat disinformation and advance population health literacy. That response might begin with implementing the recommendations set forth in the Surgeon General’s report on combating misinformation, creating policy that mandates social media algorithms boost credible science, funding research to understand how misinformation spreads and mitigate its consequences, and generating multiple strategies to discredit, combat, and dismantle sources of disinformation that harm consumers.

This response should also consider ways to enhance and amplify positive messages from trusted sources. Inspiration can be drawn from examples such as the Youth Anti-Drug Campaign or tobacco control efforts. Substantial federal government resources will be required for this effort to have a meaningful impact on vaccination rates, particularly among critical demographics like school-aged children.

This response should be paired with ongoing work to advance broader vaccine and health literacy and emphasize the need for routine and seasonal childhood vaccinations and regular wellness checks. Boosting population health literacy also requires confronting the pay walls and administrative barriers that block lay persons from consuming science texts and journal articles. It requires new laws to ensure the results of all federally-funded research are made available to the public, for free, in perpetuity, independent of the presidential administration. It requires the continual creation of proactive information campaigns to target emerging infectious threats before they become public health crises.

This collective work will require the Administration and government agencies, businesses, professional societies – including pediatric medical societies – and community-based organizations, schools and community health worker partners to work together.

5. Increase data surveillance and tracking

The CDC continues to mishandle tracking cases of COVID-19 infection. While the U.S. may approach one million cases/day of Omicron, CDC isn’t tracking cases domestically with the precision that the Weather Service tracks storms. Much has been made about outdated technology and methods used for disease reporting prior to and in the early stages of the pandemic, but progress remains slow. Decisions about what data is being collected and reported on (e.g., breakthrough cases) have been poorly communicated and a source of frustration for health officials and the public. CDC’s patchwork disease reporting system is in the process of a major overhaul. Still, without good surveillance data that instills confidence in our ability to offer guidance, course correct, and communicate accurately, the Administration appears to be under-resourced and uncoordinated. Increasing data surveillance and tracking, including strengthening reporting requirements around state-level data and funding improvements in local and state public health data infrastructure, should be an immediate priority.

6. Foster workforce leadership and effective community-driven best practices

Critical to this next phase is intentional coordination of efforts centered around the experiences of a diverse workforce with trusted providers of health information and services, coupled with trusted “health extenders” (e.g., trusted messengers in populations with lower vaccine uptake). By developing a regular “situation room” type convening that involves members of United States government (Executive Office of the President, Department of Education, HHS including CDC, HRSA, ACF), public health departments, school-based health, and community partners, the Administration can focus on diffusing accurate messages on what is working, what needs a course correction, fostering peer-to-peer learning and what can be speedily spread and scaled elsewhere.

Additionally, the Administration should leverage Medicaid redetermination grants funded by CMS and existing HRSA, OMH, and CDC COVID-related funding for state, local, tribal, and territorial health departments, CBOs, national nonprofits, and community health workforces to support unified messaging, goal-setting, training, and strategies focused on childhood vaccines tailored for these key partners. This will ensure we capitalize on opportunities at vaccination sites and ongoing community engagement to address concerns, advance family vaccine literacy and support referrals to primary care/pediatrics

7. Protect vaccinations, including the COVID-19 vaccines from commercialization to ensure their equitable distribution

The federal government has indicated that, absent additional congressional funding, it may run out of funding to purchase COVID vaccines by the end of 2022. This is unacceptable. Yet, conversations have been initiated about the process for ending universal purchase of COVID vaccine by the federal government and commercializing the vaccines. This process would shift financial burdens to the insurance marketplace, including private payers, Medicaid, and the Children’s Health Insurance Program, which will, with near certainty exacerbate existing inequities in vaccine access. Commercializing life-saving vaccines, particularly during an ongoing pandemic and in the face of emerging vaccine preventable diseases, also risks undermining the role of public health entities in effectively guaranteeing vaccine distribution and administration for the population.

In the absence of other exemplary programs to provide free vaccinations for adult populations, the Vaccines for Children Program (VFC) must become the national standard for all vaccine distribution and a central focus of the COVID vaccine strategy for children.But since COVID vaccines for some age groups are still being offered under an FDA emergency use authorization rather than full approval, these vaccines are not presently eligible for inclusion in the Vaccines for Children (VFC) program.

It is essential that the federal government extend the COVID-19 funding for vaccines so that children can access them as adults can, and appropriately shift all plans for commercialization to universal vaccine access for children and adults in the US.

8. Encourage and fund greater vaccine administration in primary care practices

As the country moves into a new stage of the COVID-19 pandemic, the federal government must intensify efforts to increase child vaccination rates for both COVID-19 and routine immunizations. Administering COVID-19 and routine vaccines has become increasingly complex, especially with the introduction of the bivalent COVID-19 booster at the same time as the flu vaccine roll out. Many pediatric practices are struggling to keep up with the increased need for counseling patients and families during a time when they are short staffed, to stay abreast of changing vaccine ordering logistics and labeling, to maintain cold storage space, and to follow conflicting messages on wastage for COVID-19 and routine vaccines. The administration must continue to ensure appropriate provider payment for vaccine counseling for both COVID-19 vaccines and routine immunizations, whether a vaccine is administered or not.

To help relieve some of the administrative burden currently associated with administering COVID-19 vaccines and participating in the Vaccines for Children (VFC) program, the federal government should ease requirements for practices, including the process and coding complexity for documentation of storage, and should promote best practices for state vaccine distribution such as distributing smaller quantities of vaccine. The Administration should also facilitate the availability and use of single-dose vials, as this will help increase provider adoption, reduce the amount of wasted COVID-19 vaccine, and ensure the feasibility of successful commercialization. Efforts to streamline and encourage the delivery of COVID vaccines in pediatric practices must occur hand-in-hand with federal government efforts to promote the need for COVID-19 and routine immunizations at the national level, as well as at a more targeted community level that can reduce disparities by reaching populations with lower vaccination rates.

These immediate action steps have the potential to change the course of the national COVID-19 response and also lay the groundwork for a stronger, more equitable pandemic response and public health infrastructure. Our Working Group welcomes questions and feedback related to these recommendations, as well as opportunities to facilitate or support their implementation. While some recommendations are more challenging than others, we must – and can – act now and work collaboratively in new ways to protect our children and families.

Source Organization(s)
The Vaccine Equity Cooperative facilitated a diverse working group of subject matter experts which produced a set of detailed recommendations for the equitable distribution of COVID-19 vaccines to children ages 5-11 years old.

CHILDREN’S VACCINE EQUITY WORKING GROUP:

FURTHER INPUT FROM AND SPECIAL THANKS TO:

Recent Resources

Args

post_type
0post
post_statuspublish
posts_per_page4
meta_query
relationAND
0Array ( )
cat
01
post__not_in
07427
orderby
dateASC
relevanssitrue

Module Settings

post_type_chooseoff|on|off|off|off|off|off|off|off|off|off
loop_stylecustom_loop_layout
shortcode_name[de_loop_template_shortcode]
loop_templatesdivi-blog
custom_loop_templatenone
loop_layout8931
filter_update_animationload-6
no_posts_layoutnone
no_posts_layout_textSorry, No posts.
is_main_loopoff
include_current_termsoff
groupping_post_objectoff
groupping_taxonomynone
show_empty_onloadoff
post_statuspublish
show_current_postoff
posts_number4
post_offset0
post_display_typerelated
saved_typewishlist
acf_linked_acfnone
related_contentcategories
related_acf_fieldnone
related_content_categoriespost_cats
is_category_loopoff
disable_sticky_postsoff
specific_post_objectsoff
related_content_tagsdefault
tax_name_relatednone
acf_name_relatednone
custom_tax_choosepost
acf_namenone
include_sticky_postson
include_sticky_posts_onlyoff
onload_tax_choosepost
sort_orderdate
acf_sort_fieldnone
acf_sort_typestring
acf_date_picker_fieldnone
acf_date_picker_methoddefault
acf_date_picker_custom_day30
order_asc_descASC
sec_acf_sort_fieldnone
sec_acf_sort_typestring
sec_acf_date_picker_fieldnone
sec_order_asc_descASC
enable_loadmoreoff
pagination_positionbottom
scrolltoon
scrollto_fine_tune0px
loadmore_textLoad More
loadmore_text_loadingLoading...
enable_resultcountoff
resultcount_positionright
result_count_single_textShowing the single result
result_count_all_textShowing all %d results
result_count_pagination_textShowing %d-%d of %d results
has_mapoff
map_all_postsoff
map_all_posts_limit-1
map_infoview_layoutnone
map_infoview_layout_ajaxoff
hide_marker_labeloff
map_clusteron
link_whole_girdoff
link_whole_gird_externaloff
external_acfnone
content_section_layoutnone
grid_layoutgrid
columns4
columns_tablet2
columns_mobile1
custom_gutter_widthoff
grid_list_defaultlist
grid_list_positionleft
grid_list_cookie_time30
grid_view_icon||divi||400
list_view_icon||fa||900
icon_padding7px|7px|7px|7px
icon_margin0px|10px|0px|0px
enable_overlayon
show_featured_imageon
show_read_moreoff
read_more_textRead More
show_authoron
show_dateon
date_formatF j, Y
show_categorieson
show_contentoff
excerpt_length270
excerpt_more...
show_commentsoff
meta_separator|
content_visibilityhover
image_hover_animationnone
loop_template_content_alignmentcenter_center
loop_template_color_themelight
loop_template_same_heighton
image_min_height150px
image_max_height500px
pagination_item_background#fff
pagination_item_background_active#ebe9eb
_builder_version4.21.0
_module_presetdefault
title_font_size14px
title_letter_spacing0px
title_line_height1em
excerpt_font_size14px
excerpt_letter_spacing0px
excerpt_line_height1em
loop_template_meta_font_size14px
loop_template_meta_letter_spacing0px
loop_template_meta_line_height1em
loop_template_meta_a_font_size14px
loop_template_meta_a_letter_spacing0px
loop_template_meta_a_line_height1em
loop_template_a_font_size14px
loop_template_a_letter_spacing0px
loop_template_a_line_height1em
pagination_font_letter_spacing0px
active_pagination_letter_spacing0px
background_enable_coloron
use_background_color_gradientoff
background_color_gradient_repeatoff
background_color_gradient_typelinear
background_color_gradient_direction180deg
background_color_gradient_direction_radialcenter
background_color_gradient_stops#2b87da 0%|#29c4a9 100%
background_color_gradient_unit%
background_color_gradient_overlays_imageoff
background_color_gradient_start#2b87da
background_color_gradient_start_position0%
background_color_gradient_end#29c4a9
background_color_gradient_end_position100%
background_enable_imageon
parallaxoff
parallax_methodon
background_sizecover
background_image_widthauto
background_image_heightauto
background_positioncenter
background_horizontal_offset0
background_vertical_offset0
background_repeatno-repeat
background_blendnormal
background_enable_video_mp4on
background_enable_video_webmon
allow_player_pauseoff
background_video_pause_outside_viewporton
background_enable_pattern_styleoff
background_pattern_stylepolka-dots
background_pattern_colorrgba(0,0,0,0.2)
background_pattern_sizeinitial
background_pattern_widthauto
background_pattern_heightauto
background_pattern_repeat_origintop_left
background_pattern_horizontal_offset0
background_pattern_vertical_offset0
background_pattern_repeatrepeat
background_pattern_blend_modenormal
background_enable_mask_styleoff
background_mask_stylelayer-blob
background_mask_color#ffffff
background_mask_aspect_ratiolandscape
background_mask_sizestretch
background_mask_widthauto
background_mask_heightauto
background_mask_positioncenter
background_mask_horizontal_offset0
background_mask_vertical_offset0
background_mask_blend_modenormal
custom_buttonoff
button_text_size18
button_bg_use_color_gradientoff
button_bg_color_gradient_repeatoff
button_bg_color_gradient_typelinear
button_bg_color_gradient_direction180deg
button_bg_color_gradient_direction_radialcenter
button_bg_color_gradient_stops#2b87da 0%|#29c4a9 100%
button_bg_color_gradient_unit%
button_bg_color_gradient_overlays_imageoff
button_bg_color_gradient_start#2b87da
button_bg_color_gradient_start_position0%
button_bg_color_gradient_end#29c4a9
button_bg_color_gradient_end_position100%
button_bg_enable_imageon
button_bg_parallaxoff
button_bg_parallax_methodon
button_bg_sizecover
button_bg_image_widthauto
button_bg_image_heightauto
button_bg_positioncenter
button_bg_horizontal_offset0
button_bg_vertical_offset0
button_bg_repeatno-repeat
button_bg_blendnormal
button_bg_enable_video_mp4on
button_bg_enable_video_webmon
button_bg_allow_player_pauseoff
button_bg_video_pause_outside_viewporton
button_use_iconon
button_icon_placementright
button_on_hoveron
positioningnone
position_origin_atop_left
position_origin_ftop_left
position_origin_rtop_left
widthauto
max_widthnone
min_heightauto
heightauto
max_heightnone
filter_hue_rotate0deg
filter_saturate100%
filter_brightness100%
filter_contrast100%
filter_invert0%
filter_sepia0%
filter_opacity100%
filter_blur0px
mix_blend_modenormal
animation_stylenone
animation_directioncenter
animation_duration1000ms
animation_delay0ms
animation_intensity_slide50%
animation_intensity_zoom50%
animation_intensity_flip50%
animation_intensity_fold50%
animation_intensity_roll50%
animation_starting_opacity0%
animation_speed_curveease-in-out
animation_repeatonce
hover_transition_duration300ms
hover_transition_delay0ms
hover_transition_speed_curveease
link_option_url_new_windowoff
sticky_positionnone
sticky_offset_top0px
sticky_offset_bottom0px
sticky_limit_topnone
sticky_limit_bottomnone
sticky_offset_surroundingon
sticky_transitionon
motion_trigger_startmiddle
hover_enabled0
title_text_shadow_stylenone
title_text_shadow_horizontal_length0em
title_text_shadow_vertical_length0em
title_text_shadow_blur_strength0em
title_text_shadow_colorrgba(0,0,0,0.4)
excerpt_text_shadow_stylenone
excerpt_text_shadow_horizontal_length0em
excerpt_text_shadow_vertical_length0em
excerpt_text_shadow_blur_strength0em
excerpt_text_shadow_colorrgba(0,0,0,0.4)
loop_template_meta_text_shadow_stylenone
loop_template_meta_text_shadow_horizontal_length0em
loop_template_meta_text_shadow_vertical_length0em
loop_template_meta_text_shadow_blur_strength0em
loop_template_meta_text_shadow_colorrgba(0,0,0,0.4)
loop_template_meta_a_text_shadow_stylenone
loop_template_meta_a_text_shadow_horizontal_length0em
loop_template_meta_a_text_shadow_vertical_length0em
loop_template_meta_a_text_shadow_blur_strength0em
loop_template_meta_a_text_shadow_colorrgba(0,0,0,0.4)
loop_template_a_text_shadow_stylenone
loop_template_a_text_shadow_horizontal_length0em
loop_template_a_text_shadow_vertical_length0em
loop_template_a_text_shadow_blur_strength0em
loop_template_a_text_shadow_colorrgba(0,0,0,0.4)
pagination_font_text_shadow_stylenone
pagination_font_text_shadow_horizontal_length0em
pagination_font_text_shadow_vertical_length0em
pagination_font_text_shadow_blur_strength0em
pagination_font_text_shadow_colorrgba(0,0,0,0.4)
active_pagination_text_shadow_stylenone
active_pagination_text_shadow_horizontal_length0em
active_pagination_text_shadow_vertical_length0em
active_pagination_text_shadow_blur_strength0em
active_pagination_text_shadow_colorrgba(0,0,0,0.4)
button_text_shadow_stylenone
button_text_shadow_horizontal_length0em
button_text_shadow_vertical_length0em
button_text_shadow_blur_strength0em
button_text_shadow_colorrgba(0,0,0,0.4)
box_shadow_stylenone
box_shadow_colorrgba(0,0,0,0.3)
box_shadow_positionouter
box_shadow_style_productnone
box_shadow_color_productrgba(0,0,0,0.3)
box_shadow_position_productouter
box_shadow_style_grid_list_view_buttonnone
box_shadow_color_grid_list_view_buttonrgba(0,0,0,0.3)
box_shadow_position_grid_list_view_buttonouter
box_shadow_style_buttonnone
box_shadow_color_buttonrgba(0,0,0,0.3)
box_shadow_position_buttonouter
text_shadow_stylenone
text_shadow_horizontal_length0em
text_shadow_vertical_length0em
text_shadow_blur_strength0em
text_shadow_colorrgba(0,0,0,0.4)
disabledoff
global_colors_info{}
0.246345996857 seconds